NYSE · Analyst Forecast

Qiagen N.V. (QGEN) Stock Forecast & Price Target

$49.75 NYSE: QGEN Market Cap $10.27B

Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 12, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering Qiagen N.V. (QGEN), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For Qiagen N.V., analysts forecast revenue rising from $2.08B in 2025 to $2.57B in 2030; the average estimate for 2030 earnings per share is $3.26; with published estimates ranging from $3.20 to $3.31; 12 analysts contribute to these figures. These are forecasts published by analysts, not results.

Analyst price targets

MeasureValue
Current priceWhat the share trades at now.$49.75
Consensus targetThe average of the price targets analysts have published.$44.14
Median targetThe middle target, less affected by a single outlier.$43.75
Highest targetThe most optimistic published target.$52.00
Lowest targetThe most pessimistic published target.$38.60
Difference from priceHow far the consensus target sits from today’s price.-11.3%

A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.

Revenue forecast (USD)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2025$2.07B$2.08B$2.09B12
2026$2.12B$2.14B$2.16B11
2027$2.20B$2.24B$2.26B12
2028$2.31B$2.37B$2.42B12
2029$2.47B$2.50B$2.53B10
2030$2.54B$2.57B$2.61B6

Earnings per share forecast

YearLowAverageHighAnalysts
2025$2.30$2.39$2.5712
2026$2.42$2.43$2.4811
2027$2.58$2.62$2.6912
2028$2.50$2.86$3.3512
2029$3.03$3.09$3.1410
2030$3.20$3.26$3.316

Qiagen N.V. (QGEN) forecast — frequently asked questions

What is the analyst price target for Qiagen N.V.?

Analysts covering Qiagen N.V. (QGEN) have a consensus price target of $44.14, 11.3% below the current price of $49.75. Published targets range from $38.60 to $52.00. A price target is a forecast, not a measure of value, and targets are revised often.

What are analysts forecasting for Qiagen N.V.'s earnings?

The average analyst estimate for Qiagen N.V. (QGEN) earnings per share in 2030 is 3.26, with individual estimates between 3.20 and 3.31.

How much revenue is Qiagen N.V. expected to make?

Analysts forecast Qiagen N.V. (QGEN) revenue of $2.57B in 2030, based on 6 published estimates.

How many analysts cover QGEN?

12 analysts contribute estimates for Qiagen N.V. (QGEN). Thin coverage makes an average less reliable.

Analyst forecasts for other Medical - Diagnostics & Research stocks

TMO forecastDHR forecastIDXX forecastA forecastWAT forecastIQV forecastNTRA forecastMTD forecastILMN forecastLH forecastAll Medical - Diagnostics & Research stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNYSE High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.